MobiHealth News October 13, 2023
Jessica Hagen

The partners were awarded a grant under the UK–Switzerland Bilateral: Collaborative R&D program to develop an AI-enabled stroke diagnosis and treatment platform.

British medtech company Brainomix and Switzerland-based remote robotic surgical company Nanoflex Robotics announced the receipt of £400,000 ($420,418) and CHF 400,000 ($443,700), respectively, to co-develop an AI-assisted magnetic navigation system for stroke-related robotic surgical tools.

Innovate UK, the innovation agency in the United Kingdom, and Innosuisse, Switzerland’s Innovation Agency, awarded the funds.

Brainomix, spun out of the University of Oxford, creates AI-enabled software to aid in treatment decision-making for stroke, cancer and lung fibrosis.

Nanoflex is a medical robotics company focusing on the treatment of ischemic stroke. The company developed a soft robotics system that inserts guidewires...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Medical Devices, Partnerships, Robotics/RPA, Technology, Trends
Related Articles:
Three Practical Reasons To Consider AI Agents For Your Organization
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
My Medical AI Holiday Wish List
In 2024, Israel Became A Global Leader In Applied AI Innovation
Let’s Be Brilliant And Give Generative AI A Purpose For Being Here

Share This Article